Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amanta HealthcareNSE:AMANTA +2.00%14 Days Inventory is 261.45 as of Mar. 2026, which is 2% above its 10-year median of 256.95. GuruFocus rates NSE:AMANTA with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 922 Drug Manufacturers companies, Amanta Healthcare ranks worse than 91% on this metric.
The historical rank and industry rank for Amanta Healthcare's Days Inventory or its related term are showing as below:
NSE:AMANTA'
s Days Inventory Range Over the Past 10 Years
Min: 213.61 Med: 256.95 Max: 369.79
Current: 369.79
During the past 5 years, Amanta Healthcare's highest Days Inventory was 369.79. The lowest was 213.61. And the median was 256.95.
NSE:AMANTA's Days Inventory is ranked worse than 91% of 922
companies
in the Drug Manufacturers industry
Industry Median: 164.72
vs NSE:AMANTA: 369.79
Amanta Healthcare's Days Inventory
declined
from Dec. 2024 (289.66) to Mar. 2026 (261.45).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Amanta Healthcare's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.35.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Amanta Healthcare's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.07.
Amanta Healthcare (NSE:AMANTA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Amanta Healthcare's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Amanta Healthcare's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Amanta Healthcare Days Inventory Related Terms
Amanta Healthcare Days Inventory Historical Data
* Premium members only.
The historical data trend for Amanta Healthcare's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Amanta Healthcare's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amanta Healthcare Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amanta Healthcare's Days Inventory distribution charts can be found below:
* The bar in red indicates where Amanta Healthcare's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amanta Healthcare (NSE:AMANTA) has a Days Inventory of 261.45 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Amanta Healthcare and its competitors. This is near median its historical median of 256.95. Over the past decade, Amanta Healthcare's Days Inventory has ranged from 213.61 to 369.79. According to the industry distribution chart, Amanta Healthcare ranks #839 out of 922 companies in the Drug Manufacturers industry, placing it in the top 91%.
Is Amanta Healthcare's Days Inventory too high?
Amanta Healthcare's current Days Inventory of 261.45 is near median its 10-year median of 256.95. Over the past 10 years, this metric has ranged from a low of 213.61 to a high of 369.79. The Drug Manufacturers industry median Days Inventory is 164.72. Amanta Healthcare's value of 261.45 is 58.7% above this industry median. Based on the distribution chart, Amanta Healthcare ranks #839 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Amanta Healthcare has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Amanta Healthcare's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Amanta Healthcare ranks #839 out of 922 companies for Days Inventory. This places Amanta Healthcare in the lower half of its industry. The industry median Days Inventory is 164.72. Amanta Healthcare's value of 261.45 is 58.7% above this benchmark. Historically, Amanta Healthcare's own Days Inventory has ranged from 213.61 to 369.79 over the past decade. While the company's 10-year median is 256.95 vs. the industry median of 164.72, Amanta Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.72, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amanta Healthcare's current Days Inventory of 261.45 is 58.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Amanta Healthcare and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amanta Healthcare's current Days Inventory is 261.45, which is near median its own 10-year median of 256.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amanta Healthcare stock overvalued right now?
Amanta Healthcare (NSE:AMANTA) has a current Days Inventory of 261.45. The current Days Inventory is 261.45, which is near median its 10-year median of 256.95 and 58.7% above the Drug Manufacturers industry median of 164.72. Amanta Healthcare's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Amanta Healthcare (NSE:AMANTA), the current Days Inventory is 261.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amanta Healthcare Ltd is a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal and Injection Strech Blow Moulding technology. It manufactures large volume parenterals and small volume parenterals in six therapeutic segments. It also manufactures medical devices. The company manufactures fluid therapy, formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc. in medical device segment. It offers wide range of closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume till 1000 ml.
14GF Score
Get the complete analysis for NSE:AMANTA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AMANTA has been successfully added to your 
